Abstract:
The electrocardiogram (ECG) in general, and the 12-lead ECG in particular, is one of the most common and widely available digital device that can be found in clinical facilities to measure the electrical activity of the heart. Therefore, it is considered the gold standard tool for this purpose. It is an inexpensive and non-invasive monitoring device that allows for rapid diagnosis of cardiovascular diseases (CVD). Among the most common CVDs there are atrial fibrillation (AFib or AF) and atrial flutter (AFlut or AFl). These two arrhythmias play a central role in the world’s healthcare systems, being among the main reasons for hospitalization, and responsible for very high costs in all countries. Moreover, even if they are not a direct cause of death, they can lead to multiple complications up to heart failure. For the reasons mentioned above, AFib, and AFlut are the focus of this thesis. The content of this thesis is divided into two projects. The overall goal is to develop methods with the help of biosignal processing, electrophysiological simulations, and machine learning to characterize the arrhythmia, support diagnosis, and predict complications or therapy outcomes. In the first project, in silico 12-lead ECGs produced from simulations at multiscale level are used to develop two signal processing algorithms for several AFlut mechanisms char- acterization: individual component, and spatial reduced recurrence quantification analysis (icRQA, and srRQA, respectively). Moreover, an analysis of the influence that the atrial and torso models have on the cardiac simulation results, thus on the resulting ECGs, is described. The findings from these two previous analyses are incorporated into the final study of the project: hybrid (in silico plus clinical data) and feature-based machine learning discrimination of three main AFlut categories (cavotricuspid isthmus-dependent, peri-mitral, and other left atrium AFlut classes). The two RQA algorithms allowed us to extract relevant features for AFlut differentiation. Analysis of models’ influence suggested that many atrial geometries should be used in the computational framework to avoid overfitting and thus leading to the incapacity of such in silico data in the clinical practice use. The final hybrid classifier demonstrated how an automatic and non-invasive discrimination of different AFlut mechanisms is possible using appropriate features, computational simulations, and taking into account the findings of the previous studies. The second project aims at estimating the location of AFib drivers with the surface ECG. Rotors and focal sources are simulated and considered as AFib drivers. A machine learning approach only trained on in silico 12-lead ECGs is implemented to discriminate between AFib drivers located near the pulmonary veins (PVs) vs. extra-PVs atrial areas. Moreover, the success of acute AFib termination by ablation procedure is studied and linked to the clinical relevance that such classifier may have in clinical practice. The last study of this second project aims at the prediction of one of the AFib complications (i.e., heart failure) using clinical single-lead ECG signals. Machine learning enabled the identification of AFib drivers located near PVs, also suggesting that PV isolation (PVI) is the most suitable therapy to terminate the arrhythmia in such cases. On the contrary, when proceeding with PVI for AFib drivers located outside the PV areas, the arrhythmia did not terminate. In these cases, physicians should plan further ablation procedures. Moreover, the use of a classifier trained only on simulated data and demonstrating to be effective on clinical test data may open the door to the use of in silico data for machine learning. To conclude, the successful prediction of AFib-induced heart failure has proven the existence of a link between some AFib cases and this serious complication, thus providing physicians with a tool to recognize when urgent action is needed to reduce patient safety risks. In all studies in which in silico ECGs are used to develop and tune the machine learning algorithms, tests on clinical data are performed to demonstrate the real applicability of these methods in healthcare. Advantages compared to existing approaches are discussed and all the studies have been published, or are under review, in peer-reviewed journals or in a conference proceeding. The results from the two projects demonstrate how simulated data can be used to develop, and improve adequate ECG signal processing methods, and how diagnosis, and therapy planning can be supported. Furthermore, the potential of the combination of simulations and machine learning for overcoming the problem of clinical data not available in large scale is demonstrated. The proposed methods can be used to support ablation procedure planning, arrhythmia diagnosis, complication prediction, and invasive procedure time reduction, and it is therefore likely to improve the outcome of the patients.